中国生物工程杂志

［1］ Snoeckx Luc H EH, Comelussen R N, Nieuw en hoven FAV, et al. Heat shock proteins and cardiovascular pathophysiology. Physiol Rev, 2001, 81(4): 14611497. 
［2］ Srivastava P. Roles of heatshock proteins in innate and adaptive immunity. Nature Rev Immunol, 2002, 2(3): 185194. 
［3］ Liu Y, Steinacker J M. Changes in skeletal muscle heat shock proteins:Pathologial significance. Frontiers in Bioscience, 2001, 6(1):D1225. 
［4］ Brown C R, Martin R L, Hansen W J, et al. The constitutive and stress inducible forms of HSP70 exhibit function similarities and interact with one another in an ATPdependent fashion. J Cell Biol, 1993,120(5): 11011112. 
［5］ Gething M, Sambrook J. Protein folding in the cell. Nature, 1992, 235(6355): 3345. 
［6］ Knowlton A A. The role of heat shock proteins in the heart. J Mol Cell Cardiol, 1995, 27(1): 121131. 
［7］ Welch W J. The mammalian heat shock (or stress) response: a cellular defense mechanism. Adv Exp Med Biol, 1987, 225: 287304. 
［8］ 李萍，富青，熊凡，等.运动应激诱导HSP70 表达与心肌缺血再灌注.微循环学杂志，2003 ,13 (4): 5557. Li P, Fu Q, Xiong F, et al. Chinese Journal of Microcirculation, 2003, 13 (4): 55-57. 
［9］ Ritossa F M. A New Puffing Pattern Induced by Temperature Shock and DNP in Drosophila. Experientia, 1962,18(12): 571573. 
［10］ Tissieres A. Proteins Synthesis in Salivary Glands of Drosophila Melanogaster: Relation to Chromosome Puffs. J Mol Biol, 1974, 85(3): 389398. 
［11］ Latchman D S. Heat shock proteins and cardiac protection. Cardiovasc Res, 2001, 51(4): 637646. 
［12］ Bluhm W F, Martin J L, Mestril R, et al. Specific heat shock proteins protect microtubules during simulated ischemia in cardiac myocytes. Am J Physiol Heart Circ Physiol, 1998, 275(6Pt2): H2243H2249. 
［13］ Mehlen P, Preville X, Chareyron P, et al. Constitutive expression human HSP27, drosophila HSP27, or human alpha Bcrystalline confers resistance to TNFinduced and oxidative stressinduced cytotoxicity in stability transfected murine 929 fibroblasts. J Immunol, 1995, 154(1): 363374. 
［14］ Pulmier J C L, Ross B M, Currie R W, et al. Transgenic mice expressing the heat shock protein 70 have improved postischemic myocardial recovery. J Clin Invest, 1995, 95(3): 18541860. 
［15］ Marber M S, Mestril R, Chi S H, et al. Overexpression of the rat inducible 70kDa heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest, 1995, 95(4): 14461456. 
［16］ Hutter J J, Mestril R, Tam E K W, et al. Overexpression of heat shock protein 72 in transgenic mice decreases infarct size in vivo. Circulation, 1996, 94(6):14081411. 
［17］ Hutter M M, Sievers R E, Barbosa V, et al. Heatshock protein induction in rat hearts:A direct correlation between the amount of heatshock protein induced and the degree of myocardial protection. Circulation, 1994, 89(1):355360. 
［18］ Iwaki K, Chi S H, Dilmann W H, et al. Induction of HSP70 in cultured rat neonatal cardiomyocytes by hypoxia and metabolic stress. Circulation, 1993, 87(6): 20232032. 
［19］ Giannessi D, Colotti C, Maltinti M, et al. Circulating heat shock proteins and inflammatory markers in patients with idiopathic left ventricular dysfunction: their relationships with myocardial and microvascular impairment. Cell Stress Chaperones, 2007, 12(3):265274. 
［20］ Kabakov A E, Budagova K R, Latchman D S, et al. Stressful preconditioning and HSP70 overexpression attenuate proteotoxicity of cellular ATP depletion. Am J Physiol Cell Physiol, 2002, 283(2):C521C534. 
［21］ Shin B H, Choi S H, Cho E Y, et al. Thiamine attenuates hypoxiainduced cell death in cultured neonatal rat cardiomyocytes. Mol Cells, 2004,18(2): 133140. 
［22］ Lu A, Ran R, ParmentierBatteur S, et al. Geldanamycin induces heat shock proteins in brain and protects against focal cerebral ischemia. J Neurochem, 2002, 81(2): 355364. 
［23］ Lubbers N L, Polakowski J S, Wegner C D, et al. Oral bimoclomol elevates heat shock protein 70 and reduces myocardial infarct size in rats. Eur J Pharmacol, 2002, 435(1): 7983. 
［24］ Mair J, Friedel W, Thomas S, et al. Natriuretic peptides in assessment of left ventricular dysfunction. Scand J Clin Lab Invest Suppl, 1999, 59(Suppl230): 132142. 
［25］ Sueta C A, Chowdhury M, Boccuzzi S J, et al. Analysis of the degree of undertreatment of hyperlipidemia and conjestive heart failure secondary to coronary artery disease. Am J Cardiol, 1999, 83(9): 13031307. 
［26］ Brown M J, Palmer C R, Castaigne A, et al. Mobidity and mortality in patients randomized to doubleblind treatment with a longacting calciumchannel blocker or diuretic in the Internatinal Nifedipine GITS study: Interventions as a goal in hypertension treatment (INSIGHT). Lancet, 2000, 356(9227): 366372.